STOCK TITAN

Zoetis (ZTS) EVP awarded 2,674 RSUs and 10,581 stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Sarbaugh Keith reported acquisition or exercise transactions in this Form 4 filing.

Zoetis Inc. Executive Vice President Keith Sarbaugh reported new equity awards. On February 18, 2026, he received 2,674 restricted stock units and 10,581 stock options under the Zoetis Amended and Restated 2013 Equity and Incentive Plan.

The RSUs each represent one share of common stock and vest in three equal installments on the first, second and third anniversaries of the grant date, subject to continued service and certain earlier-vesting events. The stock options also vest one‑third per year over three years from the grant date and expire on the tenth anniversary.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sarbaugh Keith

(Last) (First) (Middle)
C/O ZOETIS INC.
10 SYLVAN WAY

(Street)
PARSIPPANY NJ 07054

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Zoetis Inc. [ ZTS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Executive Vice President
3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit(1) (2) 02/18/2026 A 2,674 (3) (4) Common Stock 2,674 $0 2,674 D
Restricted Stock Unit(1) (2) (5) (4) Common Stock 1,159.7099 1,159.7099 D
Restricted Stock Unit(1) (2) (6) (4) Common Stock 120 120 D
Restricted Stock Unit(1) (2) (7) (4) Common Stock 1,528.0167 1,528.0167 D
Stock Option(8) $129.13 02/18/2026 A 10,581 (9) (10) Common Stock 10,581 $0 10,581 D
Stock Option(8) $156.64 (11) (10) Common Stock 4,453 4,453 D
Stock Option(8) $196.14 (12) (10) Common Stock 1,348 1,348 D
Stock Option(8) $166.44 (13) (10) Common Stock 3,142 3,142 D
Explanation of Responses:
1. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").
2. Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.
3. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
4. Not applicable.
5. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
6. One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
7. One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, March 31, 2023; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
8. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
9. One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 18, 2026.
10. Each option expires on the tenth anniversary of the date of grant.
11. One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 19, 2025.
12. One-third of each option vests on the first, second and third anniversaries of the date of grant, February 6, 2024.
13. One-third of each option vests on the first, second and third anniversaries of the date of grant, March 31, 2023.
Remarks:
/s/ Brenda Santuccio, as Attorney-in-Fact 02/19/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Zoetis (ZTS) report for Keith Sarbaugh on this Form 4?

Zoetis reported that Executive Vice President Keith Sarbaugh received grants of 2,674 restricted stock units and 10,581 stock options on February 18, 2026. These equity awards were issued under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.

How many restricted stock units did Keith Sarbaugh receive from Zoetis (ZTS)?

Keith Sarbaugh received 2,674 restricted stock units from Zoetis on February 18, 2026. Each RSU represents a contingent right to receive one share of Zoetis common stock, subject to vesting conditions tied to his continued service with the company.

What are the vesting terms for Keith Sarbaugh’s new Zoetis (ZTS) RSU grant?

One-third of Keith Sarbaugh’s 2,674 RSUs will vest on each of the first, second, and third anniversaries of the February 18, 2026 grant date. Vesting requires his continued service and may accelerate upon specified earlier events described in the award terms.

How many stock options did Keith Sarbaugh receive from Zoetis (ZTS)?

Keith Sarbaugh received 10,581 stock options on February 18, 2026. These options were granted under the Zoetis Amended and Restated 2013 Equity and Incentive Plan and give him the right to purchase Zoetis common stock subject to vesting and expiration terms.

What are the vesting and expiration terms of Keith Sarbaugh’s Zoetis (ZTS) stock options?

One-third of each stock option grant to Keith Sarbaugh will vest on each of the first, second, and third anniversaries of the February 18, 2026 grant date. Each option expires on the tenth anniversary of the grant, limiting the exercise period to that timeframe.

Under which plan were Keith Sarbaugh’s new Zoetis (ZTS) equity awards granted?

Keith Sarbaugh’s restricted stock units and stock options were granted under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan. This plan governs the terms of his RSUs, related dividend equivalent units, and stock option awards, including vesting schedules and expiration.
Zoetis Inc

NYSE:ZTS

ZTS Rankings

ZTS Latest News

ZTS Latest SEC Filings

ZTS Stock Data

53.73B
421.47M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
PARSIPPANY